Biotricity Inc. received more than $240,000 in a grant from the U.S. National Heart, Blood and Lung Institute of the National Institutes of Health to launch a study of a new algorithm to be used with its Bioflux device to assess the risk of stroke in patients with chronic kidney disease (CKD). Read More
The litigation over the fraud perpetrated by Theranos Inc. and its executives is still legally relevant, but another Silicon Valley company and its founder have been indicted over misrepresentations to investors over liquid biopsy technologies that were purported to work with just a few drops of blood. A jury recently convicted Mark Schena, the president of Palo Alto-Calif.-based Arrayit Corp., of defrauding investors and causing false claims to be submitted to federal health programs, another example of how investors can be easily misled by hucksters plying the diagnostics trade. Read More
Taiwan's Food and Drug Administration has approved Brain Navi Biotechnology Co. Ltd.’s Naotrac, an autonomous neurosurgical navigation robot that uses artificial intelligence (AI) to map out the most precise surgical pathway for minimal tissue damage to the brain. Read More
A research team led by assistant professor Min-Ho Seo of Busan, South Korea’s Pusan National University have developed a soft, bioresorbable, implantable device to relieve neuropathic pain by cooling peripheral nerves.
Angioplasty and stenting have combined to become the standard of care for patients with myocardia that sustained damage due to an infarct, but a new study suggests that some of these patients are no worse off with medical management compared to a trip to the cath lab. Read More
New hires and promotions in the med-tech industry, including: Auxilius, Checkpoint Surgical, Conformal Medical, Eagle Genomics, Longhorn Vaccines and Diagnostics, Modern Meadow, Polarityte. Read More
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott, Aposhealth, Bonesupport, Veracyte. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Axonics, BAMF, Biolog-id, Centinel Spine, Headspace Health, ITM, Lunaphore, Nucleai, Shine. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aerin Medical, Cardior, Ceribell, Quest Diagnostics, Sciton. Read More
